A systematic biology tool was developed to prioritize cancer subtype-specific drugs by integrating genetic perturbation, drug action, biological pathway, and cancer subtype. The capabilities of this tool include inferring patient-specific subpathway activity profiles in the context of gene expression profiles with subtype labels, calculating differentially expressed subpathways based on cultured human cells treated with drugs in the 'cMap' (connectivity map) database, prioritizing cancer subtype specific drugs according to drug-disease reverse association score based on subpathway, and visualization of results (Castelo (2013) <doi:10.1186/1471-2105-14-7>; Han et al (2019) <doi:10.1093/bioinformatics/btz894>; Lamb and Justin (2006) <doi:10.1126/science.1132939>). Please cite using <doi:10.1093/bioinformatics/btab011>.
Version: 0.1.9 Depends: R (≥ 2.10) Imports: BiocGenerics, GSVA, grDevices, graphics, igraph, parallel, pheatmap, rvest, stats, xml2, ChemmineR Suggests: knitr, rmarkdown, testthat (≥ 3.0.0) Published: 2024-04-17 DOI: 10.32614/CRAN.package.SubtypeDrug Author: Xudong Han, Junwei Han, Chonghui Liu Maintainer: Junwei Han <hanjunwei1981 at 163.com> BugReports: https://github.com/hanjunwei-lab/SubtypeDrug/issues License: GPL-2 | GPL-3 [expanded from: GPL (≥ 2)] NeedsCompilation: no CRAN checks: SubtypeDrug results Documentation: Downloads: Linking:Please use the canonical form https://CRAN.R-project.org/package=SubtypeDrug to link to this page.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4